Cutler Group LP Kempharm, Inc Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	SELL	$4.12 - $5.62 $5,768 - $7,868	-1,400 Reduced 87.5%	200 $1,000
Q2 2022 Aug 04, 2022	SELL	$4.02 - $5.21 $803 - $1,042	-200 Reduced 11.11%	1,600 $22,000
Q1 2022 Apr 14, 2022	SELL	$5.0 - $9.26 $2,000 - $3,704	-400 Reduced 18.18%	1,800 $21,000
Q4 2021 Jan 18, 2022	SELL	$7.6 - $10.26 $3,040 - $4,104	-400 Reduced 15.38%	2,200 $20,000
Q3 2021 Oct 26, 2021	SELL	$8.72 - $13.31 $3,488 - $5,324	-400 Reduced 13.33%	2,600 $20,000
Q2 2021 Jul 19, 2021	SELL	$8.52 - $15.47 $67,308 - $122,213	-7,900 Reduced 72.48%	3,000 $20,000
Q1 2021 Apr 26, 2021	BUY	$5.6 - $13.47 $61,039 - $146,823	10,900 New	10,900 $13,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.